{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:16:47Z","timestamp":1778649407601,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,23]],"date-time":"2026-12-23T00:00:00Z","timestamp":1797984000000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK120689"],"award-info":[{"award-number":["R01DK120689"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK124612"],"award-info":[{"award-number":["R01DK124612"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK121925"],"award-info":[{"award-number":["R01DK121925"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK097512"],"award-info":[{"award-number":["P30DK097512"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016606","name":"Riley Children&apos;s Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA028506"],"award-info":[{"award-number":["R01AA028506"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["UT2AA031151"],"award-info":[{"award-number":["UT2AA031151"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R21AG072288"],"award-info":[{"award-number":["R21AG072288"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ajpath.2025.04.014","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T19:12:22Z","timestamp":1746817942000},"page":"209-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Patatin-Like Phospholipase Domain\u2013Containing 3 148M Variant Exacerbates Alcohol-Induced Liver Injury and Tumorigenesis in Mice"],"prefix":"10.1016","volume":"196","author":[{"given":"Jung-Hyo","family":"Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeong-Geug","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2389-8680","authenticated-orcid":false,"given":"Menghao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6263-990X","authenticated-orcid":false,"given":"Alex","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7552-9957","authenticated-orcid":false,"given":"Kyle","family":"McCrocklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2260-4310","authenticated-orcid":false,"given":"Juexin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5452-6882","authenticated-orcid":false,"given":"X. Charlie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2025.04.014_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","article-title":"Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.014_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2023-100036","article-title":"Prevalence and prediction of hepatocellular carcinoma in alcohol-associated liver disease: a retrospective study of 136 571 patients with chronic liver diseases","volume":"2","author":"Chang","year":"2024","journal-title":"eGastroenterology"},{"key":"10.1016\/j.ajpath.2025.04.014_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2024-100104","article-title":"Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease","volume":"2","author":"Gao","year":"2024","journal-title":"eGastroenterology"},{"key":"10.1016\/j.ajpath.2025.04.014_bib4","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.3390\/cancers13143548","article-title":"Biochemical mechanisms associating alcohol use disorders with cancers","volume":"13","author":"Rodriguez","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpath.2025.04.014_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154515","article-title":"beta-Catenin signaling in hepatocellular carcinoma","volume":"132","author":"Xu","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2025.04.014_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev-pathol-030420-105050","article-title":"The Hippo pathway in liver homeostasis and pathophysiology","volume":"16","author":"Driskill","year":"2021","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ajpath.2025.04.014_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1053\/j.gastro.2016.10.047","article-title":"Hippo signaling in the liver regulates organ size, cell fate, and carcinogenesis","volume":"152","author":"Patel","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2025.04.014_bib8","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ng.3417","article-title":"A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis","volume":"47","author":"Buch","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2025.04.014_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.dld.2015.09.009","article-title":"PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis","volume":"48","author":"Falleti","year":"2016","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ajpath.2025.04.014_bib10","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/hep.25518","article-title":"PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis","volume":"55","author":"Trepo","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.014_bib11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fmed.2019.00304","article-title":"PNPLA3-a potential therapeutic target for personalized treatment of chronic liver disease","volume":"6","author":"Dong","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ajpath.2025.04.014_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jhep.2020.03.006","article-title":"Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping","volume":"73","author":"Liu","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.014_bib13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jcmgh.2021.04.015","article-title":"Sestrin proteins protect against lipotoxicity-induced oxidative stress in the liver via suppression of C-Jun N-terminal kinases","volume":"12","author":"Fang","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.014_bib14","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/hep.29041","article-title":"The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells","volume":"65","author":"Bruschi","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.014_bib15","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1007\/s10620-014-3279-z","article-title":"Role of the PNPLA3 I148M polymorphism in nonalcoholic fatty liver disease and fibrosis in Korea","volume":"59","author":"Lee","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ajpath.2025.04.014_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/hep.24350","article-title":"Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C","volume":"54","author":"Trepo","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.014_bib17","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/hep.23622","article-title":"Homozygosity for the patatin-like phospholipase-3\/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"51","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.014_bib18","first-page":"5212","article-title":"PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis","volume":"25","author":"Pingitore","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2025.04.014_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.molmet.2019.01.013","article-title":"Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice","volume":"22","author":"Linden","year":"2019","journal-title":"Mol Metab"},{"key":"10.1016\/j.ajpath.2025.04.014_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143429","article-title":"The impact of PNPLA3 rs738409 SNP on liver fibrosis progression, portal hypertension and hepatic steatosis in HIV\/HCV coinfection","volume":"10","author":"Scheiner","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2025.04.014_bib21","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s41588-022-01119-7","article-title":"YAP induces an oncogenic transcriptional program through TET1-mediated epigenetic remodeling in liver growth and tumorigenesis","volume":"54","author":"Wu","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2025.04.014_bib22","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jhep.2019.06.018","article-title":"ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles","volume":"71","author":"Seo","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.014_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2023-100020","article-title":"Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases","volume":"1","author":"Wen","year":"2023","journal-title":"eGastroenterology"},{"key":"10.1016\/j.ajpath.2025.04.014_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2022.109081","article-title":"The PNPLA3 variant I148M reveals protective effects toward hepatocellular carcinoma in mice via restoration of omega-3 polyunsaturated fats","volume":"108","author":"Patsenker","year":"2022","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.ajpath.2025.04.014_bib25","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/hep.30583","article-title":"PNPLA3, CGI-58, and inhibition of hepatic triglyceride hydrolysis in mice","volume":"69","author":"Wang","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.014_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1470-2045(21)00603-3","article-title":"Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study","volume":"23","author":"Trepo","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajpath.2025.04.014_bib27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2009.09.026","article-title":"Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene","volume":"16","author":"Zhou","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2025.04.014_bib28","doi-asserted-by":"crossref","first-page":"8248","DOI":"10.1073\/pnas.0912203107","article-title":"The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis","volume":"107","author":"Lee","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2025.04.014_bib29","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1073\/pnas.0911427107","article-title":"Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver","volume":"107","author":"Lu","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2025.04.014_bib30","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1073\/pnas.0911409107","article-title":"Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression","volume":"107","author":"Song","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2025.04.014_bib31","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/hep.24289","article-title":"Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice","volume":"53","author":"Kowalik","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.014_bib32","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1053\/j.gastro.2013.02.009","article-title":"Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma","volume":"144","author":"Tschaharganeh","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2025.04.014_bib33","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/hep.26420","article-title":"Mutual interaction between YAP and CREB promotes tumorigenesis in liver cancer","volume":"58","author":"Wang","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.014_bib34","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jhep.2014.06.033","article-title":"YAP activation is an early event and a potential therapeutic target in liver cancer development","volume":"61","author":"Perra","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.014_bib35","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/j.gastro.2014.05.004","article-title":"Activation of beta-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice","volume":"147","author":"Tao","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2025.04.014_bib36","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.celrep.2015.02.027","article-title":"YAP inhibition restores hepatocyte differentiation in advanced HCC, leading to tumor regression","volume":"10","author":"Fitamant","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.ajpath.2025.04.014_bib37","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1158\/0008-5472.CAN-15-0291","article-title":"An imbalance in TAZ and YAP expression in hepatocellular carcinoma confers cancer stem cell-like behaviors contributing to disease progression","volume":"75","author":"Hayashi","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2025.04.014_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/cas.12587","article-title":"TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma","volume":"106","author":"Xiao","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ajpath.2025.04.014_bib39","doi-asserted-by":"crossref","first-page":"E71","DOI":"10.1073\/pnas.1517188113","article-title":"Dysregulated YAP1\/TAZ and TGF-beta signaling mediate hepatocarcinogenesis in Mob1a\/1b-deficient mice","volume":"113","author":"Nishio","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2025.04.014_bib40","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1158\/1078-0432.CCR-15-1447","article-title":"Inactivation of Hippo pathway is significantly associated with poor prognosis in hepatocellular carcinoma","volume":"22","author":"Sohn","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2025.04.014_bib41","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/liv.13428","article-title":"Overexpression of Yes-associated protein and its association with clinicopathological features of hepatocellular carcinoma: a meta-analysis","volume":"37","author":"Lin","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.ajpath.2025.04.014_bib42","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/hep.29663","article-title":"High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis","volume":"67","author":"Chen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.014_bib43","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.aaw9886","article-title":"Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice","volume":"366","author":"Moya","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2025.04.014_bib44","doi-asserted-by":"crossref","first-page":"8711","DOI":"10.3390\/ijms21228711","article-title":"PNPLA3 I148M up-regulates Hedgehog and Yap signaling in human hepatic stellate cells","volume":"21","author":"Bruschi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2025.04.014_bib45","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jcmgh.2023.01.007","article-title":"Fueling HCC dynamics: interplay between tumor microenvironment and tumor initiating Cells","volume":"15","author":"Huang","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.014_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2023-100010","article-title":"Risk factors of primary liver cancer initiation associated with tumour initiating cell emergence: novel targets for promising preventive therapies","volume":"1","author":"Brouillet","year":"2023","journal-title":"eGastroenterology"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025001543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025001543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:04:11Z","timestamp":1778648651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944025001543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0002944025001543"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.04.014","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Patatin-Like Phospholipase Domain\u2013Containing 3 148M Variant Exacerbates Alcohol-Induced Liver Injury and Tumorigenesis in Mice","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Investigative Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}